Pharmacy Times September 25, 2025
Expert Q&A: Advancing Hematology-Oncology Through Novel Therapies and Biomarker-Driven Care
The hematology-oncology landscape is rapidly evolving, including the introduction of CAR T-cell therapies, bispecific antibodies, and biomarker-guided approaches. As treatments become more personalized and complex, pharmacists are key in ensuring safe use through education and practical tools. Advances in genetic insights continue to shape decision-making and patient outcomes. In this Q&A, expert Sean Hwang, PharmD, clinical pharmacy specialist with the Leukemia Department of Pharmacy at Memorial Sloan Kettering Cancer Center, explained how he keeps up with new literature, supports patients and care teams with complex regimens, and uses genetic information to guide leukemia therapy.
Pharmacy Times: How do you stay current with the latest developments in hematology-oncology, particularly with novel...
Today's Sponsors
Today's Sponsor